Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.
about
Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.Quinotrierixin inhibits proliferation of human retinal pigment epithelial cells.Characterization of equine hyalocytes: their immunohistochemical properties, morphologies and distribution.Long-term diabetic complications may be ameliorated by targeting Rho kinase.Disease pathways in proliferative vitreoretinopathy: an ongoing challenge.The ocular toxicity and pharmacokinetics of simvastatin following intravitreal injection in mice.ROCK as a Therapeutic Target of Diabetic RetinopathyStatin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levelsCell-mediated contraction of vitreous explants from chicken embryo: possibility of screening for therapeutic agents against proliferative vitreoretinal diseases.Proteomics of post-traumatic proliferative vitreoretinopathy in rabbit retina reveals alterations to a variety of functional proteins.Statin use and vitreoretinal surgery: Findings from a Finnish population-based cohort study.Soluble form of LR11 is highly increased in the vitreous fluids of patients with idiopathic epiretinal membrane.Lipids and Diabetic Retinopathy.Repair of primary RRD - comparing pars plana vitrectomy procedure with combined phacovitrectomy with standard foldable intraocular lens implantationStatins in rhegmatogenous retinal detachment are associated with low intravitreal angiopoietin-2, VEGF and MMP-2 levels, and improved visual acuity gain in vitrectomized patients
P2860
Q33845524-B4E4F571-E816-4E57-94FB-3774E95895CCQ36521062-98C870A1-F41D-409C-A2D1-D7D2D5C08559Q37075797-A04E4AC4-70D5-47DE-8922-F6BB09D445F5Q37838899-B24EB787-356F-49E7-AF2F-7C3B6A5897B8Q38194096-7FC7736C-EB26-4A49-9F08-7EA9FDE02DD9Q41697545-06C562A9-1332-4FFA-87CF-80ADC062A6B3Q41873958-C3D7928F-1E41-4F3E-9C15-0A1D76A028FFQ42755143-8A28DE8D-F15B-4333-9ADF-D2FDEE8BAB5BQ42846718-427254C0-3639-45D0-8EB4-65675977690FQ43876241-3C5F2E77-D78A-4C40-A29A-DA9C2C9BC06FQ48234715-FCEE6700-2866-4D7A-A413-F03BA2586E7CQ51181886-802DE92D-75E1-4F13-82E3-5DB81CFE7546Q53205337-3E3CA401-D665-407D-8C92-C53F6068D40FQ58075204-A28778F7-7CE1-48F7-91AB-3F588F8A13B4Q58075251-C219CB67-1062-4532-B525-A9444F7F4E75
P2860
Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Potent inhibition of cicatrici ...... eoretinal diseases by statins.
@en
type
label
Potent inhibition of cicatrici ...... eoretinal diseases by statins.
@en
prefLabel
Potent inhibition of cicatrici ...... eoretinal diseases by statins.
@en
P2093
P2860
P356
P1433
P1476
Potent inhibition of cicatrici ...... reoretinal diseases by statins
@en
P2093
Hiroshi Enaida
Muneki Miura
Ryoichi Arita
Shintaro Nakao
Shuhei Kawahara
Tadahisa Kagimoto
Takeshi Kita
Tatsuro Ishibashi
Yasuaki Hata
Yasutaka Mochizuki
P2860
P304
P356
10.2337/DB08-0302
P407
P577
2008-07-03T00:00:00Z